shine-logo

2020

Home » 2020

SHINE breaks ground on HQ and Therapeutics production facility

SHINE Medical Technologies LLC today announced that the company has broken ground on a new 54,000-square-foot facility that will house its corporate headquarters and a large-scale production facility for the Therapeutics division it established last year.

2022-09-08T09:13:45-05:00December 16, 2020|Safer, Healthier, Cleaner, News, News Releases, Therapeutics, 2020|

SHINE announces first sales of n.c.a. Lu-177

SHINE announced that its Therapeutics division has made its first commercial sales of lutetium-177 to multiple customers. Lutetium-177, or Lu-177, is a therapeutic isotope in demand by clinical trial sponsors because of its potential to revolutionize the treatment of cancer patients.

2022-09-08T09:15:17-05:00November 4, 2020|Healthier, News, News Releases, Medical Isotopes, Therapeutics, 2020|

SHINE closes $80-million

SHINE Medical Technologies LLC, a nuclear technology company focused on becoming the world’s leading producer of medical isotopes, announced today that it has closed an $80-million Series C financing. Fidelity Management and Research Company LLC was the largest investor in the round, which also included participation from other new investors and the company’s current investors.

2021-12-16T20:07:17-06:00September 3, 2020|News, News Releases, 2020|

NRC issues review schedule for SHINE application

SHINE Medical Technologies LLC today announced that the U.S. Nuclear Regulatory Commission (NRC) expects to make a final determination regarding the issuance of an operating license to SHINE by October 2021. SHINE’s application for a license to operate the medical isotope production facility that it is building in Janesville, Wis., was accepted and docketed by the NRC last October.

2021-12-17T17:40:23-06:00May 11, 2020|News, News Releases, 2020|

SHINE & IOCB deliver Lu-177 doses to GE

SHINE Medical Technologies LLC, the Institute of Organic Chemistry and Biochemistry (IOCB Prague) and GE Healthcare today announced the production of patient doses of the therapeutic isotope lutetium-177 (Lu-177).

2022-09-08T09:15:03-05:00January 21, 2020|Healthier, News, News Releases, Medical Isotopes, Therapeutics, 2020|
Go to Top